NuPathe is a development stage pharmaceutical company founded in early 2005 that is specializing in the acquisition and development of neuroscience therapeutics. The mission of NuPathe is to identify opportunities for therapeutic advances in the treatment of neurologic and psychiatric disorders and to license and develop compounds and technologies that meet these needs.